Severity stage | p | ||||||||
Total | Stage 1 | Stage 2 | Stage 3 | ||||||
Number | % | Number | % | Number | % | Number | % | ||
High C-reactive protein | 62 | 54.9 | 13 | 46.4 | 7 | 53.8 | 42 | 58.3 |
|
ESR | 24 | 21.2 | 5 | 17.9 | 6 | 46.2 | 13 | 18.1 |
|
Kalemia |
|
|
|
|
|
|
|
| 0.25 |
Hypokalemia | 25 | 22.1 | 4 | 14.3 | 1 | 7.7 | 20 | 27.8 |
|
Hyperkalemia | 7 | 6.2 | 2 | 7.1 | 0 | 0.0 | 5 | 6.9 |
|
Computed tomography arguments |
|
|
|
|
|
|
|
| 0.11 |
Pulmonary embolism | 2 | 1.8 | 1 | 3.6 | 0 | 0.0 | 1 | 1.4 |
|
Pneumonia suggestive of COVID-19 | 20 | 17.7 | 8 | 28.6 | 3 | 23.1 | 9 | 12.5 |
|
Parenchymal involvement > 20% | 22 | 19.5 | 6 | 21.4 | 5 | 38.5 | 11 | 15.3 |
|
Therapeutic care |
|
|
|
|
|
|
|
|
|
Admission to ICU | 25 | 22.1 | 8 | 28.6 | 2 | 15.4 | 15 | 20.8 | 0.04 |
Oxygen therapy | 15 | 13.3 | 5 | 17.9 | 2 | 15.4 | 8 | 11.1 | 0.65 |
Corticosteroids | 17 | 15.0 | 5 | 17.9 | 3 | 23.1 | 9 | 12.5 | 0.55 |
Chloroquine and Azithromicin | 34 | 30.1 | 9 | 32.1 | 2 | 15.4 | 23 | 31.9 | 0.47 |
Anticoagulant | 34 | 30.1 | 11 | 39.3 | 2 | 15.4 | 21 | 29.2 | 0.28 |
Ceftriaxone or imipenem | 36 | 31.9 | 12 | 42.9 | 3 | 23.1 | 21 | 29.2 | 0.32 |
Hemodialysis | 16 | 14.2 | 0 | 0.0 | 1 | 7.7 | 15 | 20.8 | 0.021 |